Related Experiment Video

Updated: Nov 16, 2025

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

1.3K

Management of Patent Ductus Arteriosus in Premature Infants in 2020

Sarah Parkerson1, Ranjit Philip2, Ajay Talati3

  • 1Department of Pediatrics, University of Tennessee, Memphis, TN, United States.

Frontiers in Pediatrics
|March 1, 2021
PubMed

Insights

The patent ductus arteriosus (PDA) in neonates remains a debated cardiac condition. Transcatheter PDA closure (TCPC) is introduced as a potential new treatment option for premature infants.

Area of Science:

  • Neonatal cardiology
  • Pediatric cardiac surgery
  • Perinatal medicine

Background:

  • Patent ductus arteriosus (PDA) is a common neonatal cardiac condition.
  • Treatment decisions for PDA are debated due to limited long-term benefits of interventions.
  • Practice variations persist among specialists and institutions.

Purpose of the Study:

  • To review the history, embryology, histology, and hemodynamic significance of PDA.
  • To examine the existing literature on PDA closure in premature infants.
  • To introduce transcatheter PDA closure (TCPC) as a potential therapeutic option.

Main Methods:

  • Literature review of PDA history, embryology, and hemodynamics.
  • Analysis of studies on PDA closure in premature infants.
  • Discussion of transcatheter PDA closure (TCPC) techniques and outcomes.

Main Results:

  • PDA remains a significant clinical challenge in neonates.
  • Evidence for long-term benefits of current PDA interventions is limited.
  • Transcatheter PDA closure (TCPC) shows promise as a minimally invasive option.

Conclusions:

  • The management of PDA in neonates requires careful consideration.
  • Transcatheter PDA closure (TCPC) offers a potential advancement in treating PDA in premature infants.
  • Further research is needed to establish TCPC as a standard treatment.

Keywords:
PDApatent ductus arteriosus (patent arterial duct)prematurity and low birth weightsurgical ligation of patent ductus arteriosustranscatheter ductus closure

More Related Videos

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence10:52

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence

Published on: December 23, 2022

4.5K
A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

7.0K

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
108
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
163
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
126
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
121
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
144